Neuronetics, Inc. (STIM)
NASDAQ: STIM · Real-Time Price · USD
2.690
-0.190 (-6.60%)
At close: Oct 17, 2025, 4:00 PM EDT
2.700
+0.010 (0.37%)
After-hours: Oct 17, 2025, 7:59 PM EDT
Neuronetics Market Cap
Neuronetics has a market cap or net worth of $177.88 million as of October 17, 2025. Its market cap has increased by 682.85% in one year.
Market Cap
177.88M
Enterprise Value
247.56M
1-Year Change
682.85%
Ranking
Category
Stock Price
$2.69
Market Cap Chart
Since June 28, 2018, Neuronetics's market cap has decreased from $464.84M to $177.88M, a decrease of -61.73%. That is a compound annual growth rate of -12.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 177.88M | 98.52% |
| Dec 31, 2024 | 89.60M | 6.79% |
| Dec 29, 2023 | 83.91M | -55.13% |
| Dec 30, 2022 | 187.01M | 59.02% |
| Dec 31, 2021 | 117.60M | -44.22% |
| Dec 31, 2020 | 210.82M | 151.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |